Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $8,356 - $12,210
-43 Reduced 3.84%
1,076 $214,000
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $124,461 - $168,895
-558 Reduced 33.27%
1,119 $319,000
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $2.25 Million - $2.79 Million
-12,806 Reduced 88.42%
1,677 $363,000
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $2.76 Million - $4 Million
13,484 Added 1349.75%
14,483 $2.98 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $2.19 Million - $3.49 Million
-11,229 Reduced 91.83%
999 $278,000
Q2 2022

Jul 20, 2022

SELL
$115.91 - $214.48 $8.99 Million - $16.6 Million
-77,537 Reduced 86.38%
12,228 $2.34 Million
Q1 2022

Apr 14, 2022

BUY
$127.96 - $207.36 $11.5 Million - $18.6 Million
89,765 New
89,765 $18.6 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.